NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 17 filers reported holding NEMAURA MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32 | -65.6% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $93 | +3.3% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $90 | -47.7% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $172 | – | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -58.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 238 | +41.7% | 0.00% | – |
| Q4 2021 | $1,000 | -99.3% | 168 | -99.3% | 0.00% | – |
| Q3 2021 | $150,000 | -71.2% | 24,948 | -50.4% | 0.00% | – |
| Q2 2021 | $521,000 | +8583.3% | 50,313 | +6528.9% | 0.00% | – |
| Q1 2021 | $6,000 | -71.4% | 759 | -86.1% | 0.00% | – |
| Q4 2020 | $21,000 | +950.0% | 5,479 | +741.6% | 0.00% | – |
| Q3 2020 | $2,000 | -89.5% | 651 | -68.7% | 0.00% | – |
| Q2 2020 | $19,000 | – | 2,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,842,565 | $580,408 | 0.00% |
| VANGUARD GROUP INC | 126,682 | $39,905 | 0.00% |
| UBS Group AG | 85 | $27 | 0.00% |
| NewEdge Advisors, LLC | 360 | $113 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $158 | 0.00% |
| HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,158 | $1,310 | 0.00% |
| NORTHERN TRUST CORP | 26,737 | $8,422 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $34,829 | 0.00% |